Showing results (41-50 of 83) with videos related to
Sort By:
Pageof 9
Expert Opinion on Biological Therapy|December 17, 2020
HIV-1 cure strategies: why CRISPR?Andrew J Atkins, Alexander G Allen, Will Dampier, et al.Frontiers in Microbiology|May 30, 2024
Delivering CRISPR to the HIV-1 reservoirsTheodore E Gurrola, Samuel N Effah, Ilker K Sariyer, et al.Frontiers in Immunology|February 7, 2022
Targeting CCR5 as a Component of an HIV-1 Therapeutic StrategyHager Mohamed, Theodore Gurrola, Rachel Berman, et al.DNA and Cell Biology|June 16, 2007
PMA-induced differentiation of a bone marrow progenitor cell line activates HIV-1 LTR-driven transcriptionAikaterini Alexaki, Shane J Quiterio, Yujie Liu, et al.Plos One|March 27, 2020
Morphine exposure exacerbates HIV-1 Tat driven changes to neuroinflammatory factors in cultured astrocytesKenneth Chen, Thienlong Phan, Angel Lin, et al.Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|November 13, 2013
Epigenetics, drugs of abuse, and the retroviral promoterJasmine Shirazi, Sonia Shah, Divya Sagar, et al.Scientific Reports|November 2, 2017
Designing broad-spectrum anti-HIV-1 gRNAs to target patient-derived variantsWill Dampier, Neil T Sullivan, Cheng-Han Chung, et al.Clinical Medicine Insights. Pathology|November 23, 2017
Functional Studies of CCAAT/Enhancer Binding Protein Site Located Downstream of the Transcriptional Start SiteYujie Liu, Michael R Nonnemacher, Aikaterini Alexaki, et al.Advances in Virology|August 18, 2012
Impact of Tat Genetic Variation on HIV-1 DiseaseLuna Li, Satinder Dahiya, Sandhya Kortagere, et al.Frontiers in Microbiology|January 9, 2019
Gene Editing of HIV-1 Co-receptors to Prevent and/or Cure Virus InfectionAlexander G Allen, Cheng-Han Chung, Andrew Atkins, et al.Pageof 9